GlassScriptPhysician profile
Erik Oatman
NPI 1639755754
$3,531.09
in general payments reported to CMS, 2019-2025
39 companies · $1,954 in 2025
The $1,954 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $139 · 2023: $13.05 · 2024: $1,425 · 2025: $1,954.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,392.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $459.52 | 2024-2025 | Saphnelo, Breztri, Farxiga |
| Viiv Healthcare Company | $346.93 | 2024-2025 | Rukobia, Apretude, Dovato |
| Bayer Healthcare Pharmaceuticals INC. | $302.31 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $279.17 | 2024-2025 | Pifeltro, Delstrigo, Dificid |
| Amgen INC. | $256.86 | 2024-2025 | Evenity, Prolia, Tavneos |
| Janssen Biotech, INC. | $194.85 | 2025 | Tremfya |
| Exact Sciences Corporation | $146.13 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $143.58 | 2024-2025 | |
| Aroa Biosurgery Incorporated | $138.88 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $138.28 | 2024-2025 | Rexulti |
| Radius Health, INC. | $101.52 | 2024-2025 | Tymlos |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.18 | 2024-2025 | Xifaxan |
| Dexcom, INC. | $98.43 | 2024-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $94.75 | 2024-2025 | Jardiance, Zepbound, Mounjaro |
| Novo Nordisk INC | $64.67 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Oatman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.